DMK Pharmaceuticals Corporation (DMKPQ)

DMK Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-22.23	-26.48	-45.83	-49.39	-27.51	-39.01
Depreciation & Amortization	0.64	1.48	1.44	2.33	2.96	3.1
Share-Based Compensation	-0.25	-0.34	1.98	4.1	5.87	6.54
Other Operating Activities	12.47	-0.57	4.62	22.06	-1.2	-3.28
Operating Cash Flow	-9.38	-25.9	-37.79	-20.9	-19.89	-32.66
Capital Expenditures	-0.09	-0.68	-1.22	-0.45	-2.87	-3.54
Acquisitions	0.32	4.09	1.41	0	0	0
Other Investing Activities	2.67	0.07	0.1	-0.5	-	-
Investing Cash Flow	2.9	3.48	0.28	-0.95	-2.87	-3.54
Share Issuance / Repurchase	3.6	0	57.6	18.23	13.8	37.62
Debt Issued / Paid	8.01	0	1.77	3.19	-0.5	-0.49
Other Financing Activities	-0.91	0.29	-5.43	-1.53	-1.01	-
Financing Cash Flow	10.69	0.29	53.94	19.89	12.29	37.13
Net Cash Flow	4.22	-22.13	16.43	-1.96	-10.46	0.94
Free Cash Flow	-9.47	-26.58	-39.01	-21.35	-22.75	-36.19
Free Cash Flow Margin	-261.54%	-558.88%	-1766.16%	-769.00%	-102.89%	-239.90%
Free Cash Flow Per Share	-1.34	-12.42	-18.94	-19.27	-29.90	-64.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).